BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Varghese PM, Tsolaki AG, Yasmin H, Shastri A, Ferluga J, Vatish M, Madan T, Kishore U. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies. Immunobiology 2020;225:152008. [PMID: 33130519 DOI: 10.1016/j.imbio.2020.152008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Conca W, Alabdely M, Albaiz F, Foster MW, Alamri M, Alkaff M, Al-Mohanna F, Nagelkerke N, Almaghrabi RS. Serum β2-microglobulin levels in Coronavirus disease 2019 (Covid-19): Another prognosticator of disease severity? PLoS One 2021;16:e0247758. [PMID: 33647017 DOI: 10.1371/journal.pone.0247758] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
2 Yasmin H, Saha S, Butt MT, Modi RK, George AJT, Kishore U. SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response. Adv Exp Med Biol 2021;1313:99-134. [PMID: 34661893 DOI: 10.1007/978-3-030-67452-6_6] [Reference Citation Analysis]
3 González-Candelas F, Shaw MA, Phan T, Kulkarni-Kale U, Paraskevis D, Luciani F, Kimura H, Sironi M. One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages. Infect Genet Evol 2021;92:104869. [PMID: 33915216 DOI: 10.1016/j.meegid.2021.104869] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Rajadhyaksha M, Londhe V. Microsampling: A role to play in Covid-19 diagnosis, surveillance, treatment and clinical trials. Drug Test Anal 2021;13:1238-48. [PMID: 34089576 DOI: 10.1002/dta.3107] [Reference Citation Analysis]
5 Ram V, Schaposnik LP. A modified age-structured SIR model for COVID-19 type viruses. Sci Rep 2021;11:15194. [PMID: 34312473 DOI: 10.1038/s41598-021-94609-3] [Reference Citation Analysis]
6 Carla Lorena MDS, Villalba Vizcaíno VT. Vacunación contra COVID y embarazo. Duazary 2021;18:309-20. [DOI: 10.21676/2389783x.4247] [Reference Citation Analysis]
7 Yıldız E. Comparison of pure tone audiometry thresholds and transient evoked otoacoustic emissions (TEOAE) of patients with and without Covid-19 pneumonia. American Journal of Otolaryngology 2022. [DOI: 10.1016/j.amjoto.2022.103377] [Reference Citation Analysis]
8 Kirkegaard JB, Sneppen K. Superspreading quantified from bursty epidemic trajectories. Sci Rep 2021;11:24124. [PMID: 34916534 DOI: 10.1038/s41598-021-03126-w] [Reference Citation Analysis]
9 Dhameliya TM, Nagar PR, Gajjar ND. Systematic virtual screening in search of SARS CoV-2 inhibitors against spike glycoprotein: pharmacophore screening, molecular docking, ADMET analysis and MD simulations. Mol Divers 2022. [PMID: 35132518 DOI: 10.1007/s11030-022-10394-9] [Reference Citation Analysis]
10 [DOI: 10.1101/2020.12.18.423418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Sharma HN, Latimore COD, Matthews QL. Biology and Pathogenesis of SARS-CoV-2: Understandings for Therapeutic Developments against COVID-19. Pathogens 2021;10:1218. [PMID: 34578250 DOI: 10.3390/pathogens10091218] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Joubert E, Kekeh AC, Amin CN. COVID-19 and novel mRNA vaccines in pregnancy: an updated literature review. BJOG 2021. [PMID: 34651406 DOI: 10.1111/1471-0528.16973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Hsieh MH, Beirag N, Murugaiah V, Chou YC, Kuo WS, Kao HF, Madan T, Kishore U, Wang JY. Human Surfactant Protein D Binds Spike Protein and Acts as an Entry Inhibitor of SARS-CoV-2 Pseudotyped Viral Particles. Front Immunol 2021;12:641360. [PMID: 34054808 DOI: 10.3389/fimmu.2021.641360] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Midha IK, Kumar N, Kumar A, Madan T. Mega doses of retinol: A possible immunomodulation in Covid-19 illness in resource-limited settings. Rev Med Virol 2021;31:1-14. [PMID: 33382930 DOI: 10.1002/rmv.2204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
15 Moscato G, Mazzetti P, Lucenteforte E, Rosellini A, Cara A, Quaranta P, Mainardi V, Villa P, Focosi D, Lanza M, Bianco I, Mazzoni A, Falcone M, Menichetti F, Maggi F, Lai M, Freer G, Pistello M. Assessment of automated high-throughput serological assays for prediction of high-titer SARS-CoV-2 neutralizing antibody. Journal of Clinical Virology Plus 2021;1:100016. [DOI: 10.1016/j.jcvp.2021.100016] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Ng N, Powell CA. Targeting the Complement Cascade in the Pathophysiology of COVID-19 Disease. J Clin Med 2021;10:2188. [PMID: 34069355 DOI: 10.3390/jcm10102188] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
17 Ma LL, Liu HM, Liu XM, Yuan XY, Xu C, Wang F, Lin JZ, Xu RC, Zhang DK. Screening S protein - ACE2 blockers from natural products: Strategies and advances in the discovery of potential inhibitors of COVID-19. Eur J Med Chem 2021;226:113857. [PMID: 34628234 DOI: 10.1016/j.ejmech.2021.113857] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Diendéré EA, Sondo KA, Ouédraogo AR, Dahourou DL, Cissé K, Sawadogo A, Maiga S, Kuiré M, Zida S, Kaboré PR, Minoungou CJW, Habou U, Badalo H, Zoungrana N, Ouédraogo AG, Belem AR, Zoungrana J, Poda A, Diallo I, Kaboré F, Sanou A, Kouanda S. Predictors of severe hypoxemia among COVID-19 patients in Burkina Faso (West Africa): Findings from hospital based cross-sectional study. Int J Infect Dis 2021;108:289-95. [PMID: 33894354 DOI: 10.1016/j.ijid.2021.04.007] [Reference Citation Analysis]